GGH and invasive breast carcinoma: Previous studies have confirmed that GGH is highly expressed in invasive breast cancer and ERG-negative prostate cancer in comparison with adjacent non-cancerous tissues and high GGH levels are related to poor prognosis and unfavorable clinical outcomes (Shubbar et al., 2013; Melling et al., 2017).